Adverum Biotechnologies, Inc. Stock price
Equities
ADVM
US00773U2078
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
14.14 USD | -3.55% | -4.14% | +87.83% |
Mar. 21 | Adverum Biotechnologies Files $200 Million Mixed Shelf | MT |
Mar. 19 | RBC Cuts Price Target on Adverum Biotechnologies to $2 From $3, Keeps Sector Perform, Speculative Risk | MT |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | 10M | Capitalization | 293M |
---|---|---|---|---|---|
Net income 2024 * | -111M | Net income 2025 * | -143M | EV / Sales 2024 * | - |
Net cash position 2024 * | 149M | Net cash position 2025 * | 136M | EV / Sales 2025 * | 15.8 x |
P/E ratio 2024 * |
-2.62
x | P/E ratio 2025 * |
-2.47
x | Employees | 121 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.94% |
Latest transcript on Adverum Biotechnologies, Inc.
1 day | -3.55% | ||
1 week | -4.14% | ||
Current month | -28.59% | ||
1 month | -28.22% | ||
3 months | +87.04% | ||
6 months | -7.58% | ||
Current year | +87.83% |
Managers | Title | Age | Since |
---|---|---|---|
Laurent Fischer
CEO | Chief Executive Officer | 60 | 20-06-14 |
Linda Rubinstein
DFI | Director of Finance/CFO | 58 | 22-12-11 |
Bill Tan
CTO | Chief Tech/Sci/R&D Officer | - | 21-02-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 64 | 20-04-15 | |
Clarence Machado
CHM | Chairman | 60 | 17-03-13 |
Laurent Fischer
CEO | Chief Executive Officer | 60 | 20-06-14 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 14.14 | -3.55% | 109,879 |
24-03-27 | 14.66 | +3.60% | 166,895 |
24-03-26 | 14.15 | -5.35% | 682,661 |
24-03-25 | 14.95 | -6.91% | 357,284 |
24-03-22 | 16.06 | +8.88% | 576,559 |
Delayed Quote Nasdaq, March 28, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+87.83% | 293M | |
+2.73% | 108B | |
+9.59% | 103B | |
+6.58% | 23.48B | |
-12.59% | 21.93B | |
-3.29% | 19.68B | |
-35.36% | 18.37B | |
-13.29% | 16.33B | |
+4.68% | 13.72B | |
+34.25% | 12.15B |